Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 2Lymphoma 2Glioma 2Brain Neoplasms 2Leukemia, Lymphoid 1Disease Progression 1

Interventions

venetoclax 1vandetanib 1tremelimumab 1ricolinostat 1pomalidomide 1pembrolizumab 1pazopanib 1niraparib 1ibrutinib 1enzastaurin 1durvalumab 1copanlisib 1brigatinib 1binimetinib 1avasopasem manganese 1abexinostat 1Transplantation, Autologous 1Steroids 1Melphalan 1Interleukin-2 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Dexamethasone 1Blood Specimen Collection 1Biopsy 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Disease Progression × enzastaurin × Clear all
NCT00108056 2019-12-05

Enzastaurin to Treat Recurrent Brain Tumor

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
26 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡